Lucid Diagnostics Free Cash Flow (FCF) History (LUCD)

Lucid Diagnostics reported −$46.7M in free cash flow for fiscal 2025, a decrease of $2.2M from the previous fiscal year, with a free cash flow margin of −991.97%.

View full Lucid Diagnostics company overview

Lucid Diagnostics free cash flow by year

Lucid Diagnostics annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$46.7M−$2.2M−991.97%
20242024-12-31−$44.4M−$11.6M−1022.46%
20222022-12-31−$32.9M−$14.4M−8722.81%
20212021-12-31−$18.5M−3706.00%

Lucid Diagnostics free cash flow growth trends

Lucid Diagnostics's latest reported quarter, Q2 2026, generated −$11.3M in free cash flow, a decrease of $4.2M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Lucid Diagnostics filings at SEC.gov ↗